Loading organizations...
Loading organizations...
Develops small molecule therapeutics for hematologic disorders.
HemaQuest Pharmaceuticals has raised $29.0M across 3 funding rounds.
HemaQuest Pharmaceuticals has raised $29.0M in total across 3 funding rounds.
HemaQuest Pharmaceuticals has raised $29.0M in total across 3 funding rounds.
HemaQuest Pharmaceuticals's investors include James Woody, Aberdare Ventures, De Novo Ventures, Forward Ventures, Lilly Ventures, Naheed Ismaili Misfeldt.
HemaQuest Pharmaceuticals has raised $29.0M across 3 funding rounds. Most recently, it raised $13.0M Series B Extension in March 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 12, 2012 | $13.0M Series B Extension | ||
| Jul 28, 2010 | $4.0M Series B Extension | James Woody | Aberdare Ventures, De Novo Ventures, Forward Ventures, Lilly Ventures |
| Apr 21, 2010 | $12.0M Series B | Naheed Ismaili Misfeldt | De Novo Ventures, Forward Ventures, Lilly Ventures |